Surgical risks and outcome of pancreas retransplants

被引:23
作者
Humar, A [1 ]
Kandaswamy, R [1 ]
Drangstveit, MB [1 ]
Parr, E [1 ]
Gruessner, AG [1 ]
Sutherland, DER [1 ]
机构
[1] Univ Minnesota, Sch Med, Dept Surg, Minneapolis, MN 55455 USA
关键词
D O I
10.1067/msy.2000.105034
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. The increased popularity of pancreas transplants has led to an increased number potential candidates for retransplants after the initial graft has been lost to technical failure or rejection. We studied a group of recipients who underwent pancreas transplants at a single center to determine whether retransplant recipients were at higher risk of complications. Methods. Between June 1, 1994, and Dec 31, 1997, a total of 213 pancreas transplants were performed at the University of Minnesota. Of these, 187 were primary transplants and 26 were retransplants. Demographically, the two groups were not significantly different. We analyzed and compared the two groups with respeect to incidence of surgical complications, graft survival rates, and patient survival rates. Results. Surgical complications such as bleeding and vascular thrombosis were slightly more common after retransplants, but this trend did not quite reach statistical significance. Infectious complications and leaks were equivalent between the two groups. The incidence of acute rejection was higher after retransplants (P = .02). At 3 years postransplant, patient survival was no different between the two 97 groups, but pancreas graft survival was lower after retransplants (P = .08). The incidence of early graft loss (by 6 months posttransplant) was significantly higher in retransplant recipients (27% vs 14%, P = .04). Conclusions, Pancreas retransplants can be performed with a minimal increase in surgical complications. However, graft survival after retransplants is slightly inferior to that after primary transplants, probably for both immunologic and nonimmunologic reasons. Retransplants can be offered Co suitable candidates, but they may require more aggressive monitoring for rejection.
引用
收藏
页码:634 / 640
页数:7
相关论文
共 24 条
[1]   RISK-FACTORS FOR 2ND RENAL-ALLOGRAFTS IMMUNOSUPPRESSED WITH CYCLOSPORINE [J].
ALMOND, PS ;
MATAS, AJ ;
GILLINGHAM, K ;
TROPPMANN, C ;
PAYNE, W ;
DUNN, D ;
SUTHERLAND, D ;
NAJARIAN, JS .
TRANSPLANTATION, 1991, 52 (02) :253-258
[2]  
FASOLA CG, 1989, TRANSPLANT P, V21, P2165
[3]  
Gruessner A, 1994, Clin Transpl, P47
[4]  
Gruessner AC, 1998, CLIN TRANS, P53
[5]  
GRUESSNER RWG, 1994, TRANSPLANTATION, V57, P1598
[6]   The surgical risk of pancreas transplantation in the cyclosporine era: An overview [J].
Gruessner, RWG ;
Sutherland, DER ;
Troppmann, C ;
Benedetti, E ;
Hakim, N ;
Dunn, DL ;
Gruessner, AC .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1997, 185 (02) :128-144
[7]  
GRUESSNER RWG, 1994, SURG ROUNDS, V17, P311
[8]  
GRUESSNER RWG, 1996, SOLID ORGAN TRANSPLA, P455
[9]  
GRUESSNER RWG, 1994, SURG ROUNDS, V17, P383
[10]   Surgical complications requiring early relaparotomy after pancreas transplantation: Comparison of the cyclosporine and FK 506 eras [J].
Humar, A ;
Harmon, J ;
Gruessner, A ;
Kandaswamy, R ;
Granger, D ;
Zheng, C ;
Drangstveit, MB ;
Sutherland, D ;
Gruessner, R .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :606-607